Digital Immunohistochemistry Analysis of Intratumoral Immune Infiltrates in Prostate Cancer Patients Treated With Intraprostatic/Systemic PSA-TRICOM Vaccine

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p97
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

PSA Levels and Prognosis in Patients With Hormone-Refractory Prostate Cancer Treated With Low-Dose Dexamethasone

Japanese Journal of Urology
Urology
2001English

Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Analysis of Overall Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Vaccine, Nilutamide, and Combination Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

Prostate Cancer Screening With PSA: "Aequanimitas"

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2013English

Intratumoral Delivery of Tavokinogene Telseplasmid Yields Systemic Immune Responses in Metastatic Melanoma Patients

Annals of Oncology
MedicineOncologyHematology
2020English

The Relationship of PSA, PSAD and Clinicopathological Stage in Patients With Prostate Cancer

Chinese Journal of Clinical Oncology
Cancer ResearchOncology
2007English

Metastatic Prostate Cancer With Highest Reported PSA Level

Acta Medica Marisiensis
2016English

Hormonal Study in Patients With Prostate Cancer With PSA at Diagnosis Between 4-10 Ng/Ml and PSA Free/Total <20%

ACTUALIDAD MEDICA
2015English

Radiation-Induced Complications in Prostate Cancer Patients Treated With Radiotherapy

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy